| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/06/2011 | CN102000035A Zoledronic acid composition for injection and preparation method thereof |
| 04/06/2011 | CN102000028A Solamargine liposome, preparation method and usage thereof |
| 04/06/2011 | CN101999648A Extraction method of anthocyanin and original anthocyanin components in cranberry fruits |
| 04/06/2011 | CN101757602B Traditional Chinese medicine composition for treating cardiac carcinoma and preparation method thereof |
| 04/06/2011 | CN101711764B Tegafur compound capsules floating in stomach for curing gastric cancer |
| 04/06/2011 | CN101627988B Application of structure modified products of salvianolic acid B in pharmacy |
| 04/06/2011 | CN101618056B Great burdock achene Chinese herb soft capsule preparation and preparation method thereof |
| 04/06/2011 | CN101618021B Chitosan coating medicine slow release microsphere and preparation method thereof |
| 04/06/2011 | CN101590176B Chinese medicinal preparation for treating esophagus cancer |
| 04/06/2011 | CN101569634B 抗老化剂 Anti-aging agents |
| 04/06/2011 | CN101560266B Oil-tea camellia husk polysaccharide and application thereof |
| 04/06/2011 | CN101497652B Peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 04/06/2011 | CN101474350B Method for extracting total saponin in asparagus and use thereof |
| 04/06/2011 | CN101461787B Preparation method of hydroxycamptothecin nano crystal lyophilized powder for injection preparation |
| 04/06/2011 | CN101429523B Type T non--viral vector and composite medicament containing the same |
| 04/06/2011 | CN101417078B Chinese herbal medicine preparation for treating leukaemia |
| 04/06/2011 | CN101396373B Cinobufacini extract and preparation method thereof |
| 04/06/2011 | CN101391995B Water-soluble paclitaxel ester compounds containing 1,2,3-triazole and preparation method |
| 04/06/2011 | CN101371875B Method for extracting and preparing total saponin of compound abnormal savda mature agent |
| 04/06/2011 | CN101352560B Medicament for treating tumor |
| 04/06/2011 | CN101348495B Thiazolo-[3,2-a] pyridine compound and use thereof as Bcl-2 family protein antagonist |
| 04/06/2011 | CN101337065B Use of MG132 in preparing medicine for synergistic inductive differentiation therapy of leukaemia |
| 04/06/2011 | CN101317818B Methopterin intralipid, its freeze drying agent, preparation method and application thereof |
| 04/06/2011 | CN101293894B Preparing intermediate of 2-propylidene-19-nor-vitamin D compounds |
| 04/06/2011 | CN101262861B Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 04/06/2011 | CN101259122B Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/06/2011 | CN101259121B Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/06/2011 | CN101234181B Medicament for preventing and treating leukopenia used in tumor radiotherapy and chemotherapy course |
| 04/06/2011 | CN101173282B Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 04/06/2011 | CN101139387B Recombinant soluble human FGFR2 extracellular fragment and production method and application thereof |
| 04/06/2011 | CN101130491B Oligomer having fatty acid synthase restraining activity and uses thereof |
| 04/06/2011 | CN101116747B Cytosine arabinoside and gland correlated virus composite preparations and uses thereof |
| 04/06/2011 | CN101069743B Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases |
| 04/06/2011 | CN101065129B A combination of n-(3-metoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic agent for the treatment of cancer |
| 04/06/2011 | CN101035810B Modulators of hepatocyte growth factor activator |
| 04/06/2011 | CN101020026B Honeyed Guiqi ointment for enhancing body's resistance and its preparation |
| 04/06/2011 | CN101011420B Preparing process and usage of grease of housefly larva and fatty acid thereof |
| 04/06/2011 | CN100998769B Chinese medicine decoction for anti-cancer and strengthening the body resistance |
| 04/05/2011 | US7919614 Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2011 | US7919606 Biological products |
| 04/05/2011 | US7919524 Compounds, compositions and methods |
| 04/05/2011 | US7919520 Inhibitors of tace |
| 04/05/2011 | US7919517 Indazole derivatives |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919493 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent |
| 04/05/2011 | US7919490 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/05/2011 | US7919467 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 04/05/2011 | US7919458 Method of inhibiting prostate cancer cell proliferation |
| 04/05/2011 | US7919311 Compositions and methods for activating genes of interest |
| 04/05/2011 | US7919123 Composition and method for treating or preventing gastrointestinal cancer |
| 04/05/2011 | US7919098 ErbB-3 based methods and compositions for treating neoplasms |
| 04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
| 04/05/2011 | US7919087 Immunoglobulin fusion fo use indiagnosis, treatment and prevention of cell proliferative, autoimmune, blood and nervous system disorders |
| 04/05/2011 | US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL) |
| 04/05/2011 | US7919076 PH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2476825C Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases |
| 04/05/2011 | CA2475434C Aromatic amino acid derivatives and medicinal compositions |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 04/05/2011 | CA2463348C Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 04/05/2011 | CA2408747C Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 04/05/2011 | CA2344168C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/05/2011 | CA2330916C Triterpene compositions and methods for use thereof |
| 04/01/2011 | CA2697568A1 Cancer therapy |
| 03/31/2011 | WO2011038278A2 Micelle encapsulation of therapeutic agents |
| 03/31/2011 | WO2011038160A2 Compositions and methods for silencing genes expressed in cancer |
| 03/31/2011 | WO2011038159A2 Dr5 ligand drug conjugates |
| 03/31/2011 | WO2011038149A2 Methods of treating inflammation |
| 03/31/2011 | WO2011038142A2 Bladder cancer specific ligand peptides |
| 03/31/2011 | WO2011038139A1 Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane |
| 03/31/2011 | WO2011037252A1 Liposome preparation containing spicamycin derivative |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011037160A1 Antibody capable of recognizing hla class i |
| 03/31/2011 | WO2011036904A1 Agent for preventing adverse side effects of carcinostatic agent |
| 03/31/2011 | WO2011036879A1 Transferrin liposome preparation |
| 03/31/2011 | WO2011036651A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/31/2011 | WO2011036648A1 Polymorphs of sorafenib acid addition salts |
| 03/31/2011 | WO2011036505A1 New 6-substituted pyrimidine derivatives |
| 03/31/2011 | WO2011036487A1 Cancer therapy |
| 03/31/2011 | WO2011036478A1 Piperidine and piperazine derivatives as smo antagonists |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011036440A1 Antagonists of dsg2 for treatment of cancer |
| 03/31/2011 | WO2011036303A1 New aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the met family |
| 03/31/2011 | WO2011036299A1 Irreversible inhibitors useful for the treatment of kinase-related pathologies |
| 03/31/2011 | WO2011036284A1 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | WO2011036280A1 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | WO2011036118A1 Treating cancer by modulating mex-3 |
| 03/31/2011 | WO2011035941A1 Lysine specific demethylase-1 inhibitors and their use |
| 03/31/2011 | WO2011035855A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
| 03/31/2011 | WO2011035540A1 4-(substituted anilino)quinazoline derivatives as tyrosine kinase inhibitors |
| 03/31/2011 | WO2011035534A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 03/31/2011 | WO2011035465A1 Specific binding proteins and uses thereof |
| 03/31/2011 | WO2011015333A3 Targeting of bone marrow neovasculature |
| 03/31/2011 | WO2011012698A3 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 03/31/2011 | WO2011004195A3 Cyclic triazo sodium channel blockers |
| 03/31/2011 | WO2010144499A3 Urea derivatives as kinase inhibitors |
| 03/31/2011 | WO2010141680A3 Hedgehog pathway antagonists and methods of use |